Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)
Clinical trial NCT00488982 · COMPLETED
Trial details
- NCT number
- NCT00488982
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2014-03-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.